Quick Takeaways
- Alyeska Investment Group, L.P. filed SCHEDULE 13G/A for KIORA PHARMACEUTICALS, INC. Common Stock, $0.01 par value (KPRX).
- Disclosed ownership: 2.5%.
- Date of event: 31 Dec 2024.
Alyeska Investment Group, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for KIORA PHARMACEUTICALS, INC. Common Stock, $0.01 par value (KPRX)
- Filing Manager
- Alyeska Investment Group, L.P.
- Reporting Manager
- Alyeska Investment Group, L.P.
- Symbol
- KPRX
- Shares outstanding
- 3,025,120 shares
- Disclosed Ownership
- 75,628 shares
- Ownership
- 2.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 16:25:34 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Alyeska Investment Group, L.P. disclosed 2.5% ownership in KIORA PHARMACEUTICALS, INC. Common Stock, $0.01 par value (KPRX) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 16:25.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 2.5% | 75,628 | 0 | 75,628 | Jason Bragg | Jason Bragg | Chief Financial Officer | |
| Alyeska Fund GP, LLC | 2.5% | 75,628 | 0 | 75,628 | Jason Bragg | Jason Bragg | Chief Financial Officer | |
| Anand Parekh | 2.5% | 75,628 | 0 | 75,628 | Anand Parekh | Anand Parekh | Self |